News for hackers. Stuff that matters.
Re:SARS-CoV-2 variant A.30 is heavily mutated and evades vac... by angelzen on Tuesday October 26, 2021 @03:43PM (#29005314)
Thanks for the links! Note that they are making variant-specific vaccines, not proving that variant-specific vaccines are effective against the target variant, if delivered after the original vaccine.

Side note: I hope we can do better than taking at face value investor press releases by the biopharma corps producing the vaccines.

Re:SARS-CoV-2 variant A.30 is heavily mutated and evades vac... by greg5green on Tuesday October 26, 2021 @04:05PM (#29005586)
>Note that they are making variant-specific vaccines, not proving that variant-specific vaccines are effective against the target variant, if delivered after the original vaccine.

You are correct that it isn't proving vaccine efficacy, but it is showing a different set of antibodies created by the variant vaccines that are more effective at neutralizing the targeted variant than the antibody collection created by the original, WT-targeted vaccine.

>Side note: I hope we can do better than taking at face value investor press releases by the biopharma corps producing the vaccines.

I hate science by press release too. I wish I was better at bookmarking the pre-prints and journal articles I find/read, but they'd just be a mess I couldn't find anything in either :|